financetom
Business
financetom
/
Business
/
Exxon sees first LNG from Mozambique project in 2030
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exxon sees first LNG from Mozambique project in 2030
Nov 9, 2024 11:54 AM

CAPE TOWN, Nov 7 (Reuters) - Exxon Mobil ( XOM ) is

expecting the first liquefied natural gas (LNG) output from its

project in Mozambique in 2030, a company executive said on

Thursday.

Exxon along with partners including Eni and China's

CNPC are developing an LNG project in northern Mozambique, with

the U.S. energy giant leading the construction and operation of

the onshore liquefaction and related facilities.

"We will most likely next year start some early works in

(the) Afungi (site) to get things going, keep it on track and

allowing us to get first LNG (production) in 2030," Frank

Kretschmer, general manager at the company's Mozambique unit,

told delegates at an energy conference in Cape Town.

The company said on Wednesday that it now expected a

final investment decision for its Rovuma LNG project in

Mozambique in early 2026. The cost of the project is estimated

at about $30 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Gainers
Top Premarket Gainers
Apr 11, 2024
07:44 AM EDT, 04/11/2024 (MT Newswires) -- Rallybio Corp. ( RLYB ) shares nearly doubled Thursday premarket after the company said it formed a collaboration with Johnson & Johnson to develop therapies for pregnant women at risk of fetal and neonatal alloimmune thrombocytopenia. Eliem Therapeutics ( ELYM ) shares surged almost 53% on a deal to acquire Tenet Medicines. Alpine...
Vertex Pharmaceuticals' $4.9 Billion Deal for Alpine Shows Lead-Candidate's Potential, Analysts Say
Vertex Pharmaceuticals' $4.9 Billion Deal for Alpine Shows Lead-Candidate's Potential, Analysts Say
Apr 11, 2024
07:43 AM EDT, 04/11/2024 (MT Newswires) -- Vertex Pharmaceuticals' ( VRTX ) deal to acquire Alpine Immune Sciences ( ALPN ) for $4.9 billion shows the strong potential of its lead product in kidney-disease treatment and broader possibilities in other autoimmune illnesses, according to analysts. Vertex said late Wednesday that it will buy Alpine for $65 a share, which RBC...
TransAlta CFO to Retire, To Be Replaced By TC Energy's Joel E. Hunter ; Shares Up 1.3% In US Premarket
TransAlta CFO to Retire, To Be Replaced By TC Energy's Joel E. Hunter ; Shares Up 1.3% In US Premarket
Apr 11, 2024
07:49 AM EDT, 04/11/2024 (MT Newswires) -- TransAlta Corp. ( TAC ) said Thursday that Todd Stack will retire as executive vice-president of finance and chief financial officer of the company, effective June 30. The company's board has tapped Joel Hunter to serve as executive vice president of finance and CFO, effective July 1. Hunter is currently serving as executive...
STERIS to Sell Dental Business to Peak Rock Capital for $787.5 Million in Equity Transaction
STERIS to Sell Dental Business to Peak Rock Capital for $787.5 Million in Equity Transaction
Apr 11, 2024
07:43 AM EDT, 04/11/2024 (MT Newswires) -- STERIS ( STE ) said Thursday it signed a deal to sell its dental business to Peak Rock Capital for $787.5 million in an equity transaction. STERIS ( STE ) said it is eligible for additional earnout of up to $12.5 million from the sale, given that the dental segment reaches certain revenue...
Copyright 2023-2026 - www.financetom.com All Rights Reserved